Ultrasonography in the diagnosis of asymptomatic hyperuricemia and gout

References

• Puig, J.G.; Martínez, M.A.; Mora, M.; Fraile, J.M.; Montoya, F.; Torres, R.J. Serum urate, metabolic syndrome and cardiovascular risk factors. A population based study. Nucleosides Nucleotides Nucleic Acids 2008, 27, 620–623.
   PubMed Web of Science ®Google Scholar
• Zhang, W.; Doherty, M.; Bardin, T.; Pascual, E.; Barskova, V.; Conaghan, P.; Gerster, J.; Jacobs, J.; Leeb, B.; Lioté, F.; McCarthy, G.; Netter, P.; Nuki, G.; Perez-Ruiz, F.; Pignone, A.; Pimentão, J.; Punzi, L.; Roddy, E.; Uhlig, T.; Zimmermann-Gòrska, I. EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 2006, 65, 1312–1328.
   PubMed Web of Science ®Google Scholar
• Smith, E.; Hoy, D.; Cross, M.; Merriman, T.R.; Vos, T.; Buchbinder, R.; Woolf, A.; March, L. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann. Rheum. Dis. 2014, 73, 1470–1476.
   PubMed Web of Science ®Google Scholar
• Choi, H.K.; Atkinson, K.; Karlson, E.W.; Crhan, G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the Health Professionals' Follow-up Study. Arch. Intern. Med. 2005, 165, 742–748.
   PubMed Web of Science ®Google Scholar
• Choi, J.W.; Ford, E.S.; Gao, X.; Choi, H.K. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis. Rheum. 2008, 59, 109–116.
   PubMed Web of Science ®Google Scholar
• Puig, J.G.; Torres, R.J.; de Miguel, E.; Sánchez, A.; Bailén, R.; Banegas, J.R. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders. Metabolism 2012, 61, 512–518.
   PubMed Web of Science ®Google Scholar
• Torres, R.J.; de Miguel, E.; Bailen, R.; Banegas, J.R.; Puig, J.G. Tubular urate transporter gene polymorphisms discriminate patients with gout who have normal and decreased urinary uric acid excretion. J. Rheumatol. 2014, 41, 1863–1870.
   PubMed Web of Science ®Google Scholar
• Ichida, K.; Matsuo, H.; Takada, T.; Nakayama, A.; Murakami, K.; Shimizu, T.; Yamanashi, Y.; Kasuga, H.; Nakashima, H.; Nakamura, T.; Takada, Y.; Kawamura, Y.; Inoue, H.; Okada, C.; Utsumi, Y.; Ikebuchi, Y.; Ito, K.; Nakamura, M.; Shinohara, Y.; Hosoyamada, M.; Sakurai, Y.; Shinomiya, N.; Hosoya, T.; Suzuki, H. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat. Commun. 2012, 3, 764.
   PubMed Web of Science ®Google Scholar
• Takada, T.; Ichida, K.; Matsuo, H.; Nakayama, A.; Murakami, K.; Yamanashi, Y.; Kasuga, H.; Shinomiya, N.; Suzuki, H. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion. Nucleosides Nucleotides Nucleic Acids 2014, 33, 275–281.
   PubMed Web of Science ®Google Scholar
• Strazzullo, P.; Puig, J.G.; Uric acid and oxidative stress: Relative impact on cardiovascular risk. Nutr. Metab. Cardiovasc. Dis. 2007, 17, 409–414.
   PubMed Web of Science ®Google Scholar
• Kanabrocki, E.L.; Third, J.L.; Ryan, M.D.; Nemchausky, B.A.; Shirazi, P.; Scheving, L.E.; McCormick, J.B.; Hermida, R.C.; Bremner, W.F.; Hoppensteadt, D.A.; Fareed, J.; Olwin, J.H. Circadian relationship of serum uric acid and nitric oxide. JAMA 2000, 283, 2240–2241.
   PubMed Web of Science ®Google Scholar
• Neogi, T. Clinical practice: Gout. N. Engl. J. Med. 2011, 364, 443–452.
   PubMed Web of Science ®Google Scholar
• Grainger, R.; Dalbeth, N.; Keen, H.; Durcan, L.; Edwards, N.L.; Perez-Ruiz, F.; Diaz-Torne, C.; Singh, J.A.; Khanna, D.; Simon, L.S.; Taylor, W.J. Imaging as an outcome measure in gout studies: Report from the OMERACT gout working group. J. Rheumatol. 2015 Feb 1. pii: jrheum.141164. [Epub ahead of print] PubMed PMID: 25641895.
   PubMed Web of Science ®Google Scholar
• Stamp, L.; Dalbeth, N. Screening for hyperuricaemia and gout: A perspective and research agenda. Nat Rev Rheumatol 2014, 10, 752–756
   PubMed Web of Science ®Google Scholar
• González-Senac, N.M.; Bailén, R.; Torres, R.J.; de Miguel, E.; Puig, J.G. Metabolic syndrome in primary gout. Nucleosides Nucleotides Nucleic Acids 2014, 33, 185–191.
   PubMed Web of Science ®Google Scholar
• Kim, S.Y.; Guevara, J.P.; Kim, K.M.; Choi, H.K.; Heitjan, D.F.; Albert, D.A. Hyperuriceia and risk of stroke: A systematic review and meta-analysis. Arthritis Rheum. 2009, 61, 885–892.
   PubMed Web of Science ®Google Scholar
• Borghi. C.; Rosei, E.A.; Bardin, T.; Dawson, J.; Dominiczak, A.; Kielstein, J.T.; Manolis, A.J.; Perez-Ruiz, F.; Mancia, G. Serum uric acid and the risk of cardiovascular and renal disease. J. Hypertens. 2015, 33, 1729–1741.
   PubMed Web of Science ®Google Scholar
• Duskin-Bitan, H.; Cohen, E.; Goldberg, E.; Shochat, T.; Levi, A.; Garty, M.; Krause, I. The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort. Clin. Rheumatol. 2014, 33, 549–553.
   PubMed Web of Science ®Google Scholar
• Khanna, D.; Fitzgerald, J.D.; Khanna, P.P.; Bae, S.; Singh, M.K.; Neogi, T.; Pillinger, M.H.; Merill, J.; Lee, S.; Prakash, S.; Kaldas, M.; Gogia, M.; Perez-Ruiz, F.; Taylor, W.; Lioté, F.; Choi, H.; Singh, J.A.; Dalbeth, N.; Kaplan, S.; Niyyar, V.; Jones, D.; Yarows, S.A.; Roessler, B.; Kerr, G.; King, C.; Levy, G.; Furst, D.E.; Edwards, N.L.; Mandell, B.; Schumacher, H.R.; Robbins, M.; Wenger, N.; Terkeltaub, R. American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. (Hoboken), 2012, 64, 1431–1446.
   PubMed Web of Science ®Google Scholar
• Sivera, F.; Andrés, M.; Carmona, L.; Kydd, A.S.R.; John Moi, J.; Seth, R.; Sriranganathan, M.; van Durme, C.; van Echteld, I.; Vinik, O.; Wechalekar, M.D.; Aletaha, D.; Bombardier, C.; Buchbinder, R.; Edwards, C.J.; Landewé, R.B.; Bijlsma, J.W.; Branco, J.C.; Burgos-Vargas, R.; Catrina, A.I.; Elewaut, D.; Ferrari, A.J.; Kiely, P.; Leeb, B.F.; Montecucco, C.; Müller-Ladner, U.; Ostergaard, M.; Zochling, J.; Falzon, L.; van der Heijde, D.M. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann. Rheum. Dis. 2014, 73, 328–335.
   PubMed Web of Science ®Google Scholar
• Yamanaka, H. Japanese society of gout and nucleic acid metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011, 30, 1018–1029.
   PubMed Web of Science ®Google Scholar
• Puig, J.G.; de Miguel, E.; Castillo, M.C.; Rocha, A.L.; Martínez, M.A.; Torres, R.J. Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids. 2008, 27, 592–595.
   PubMed Web of Science ®Google Scholar
• Pineda, C.; Amezcua-Guerra, L.M.; Solano, C.; Rodriguez-Henríquez, P.; Hernández-Díaz, C.; Vargas, A.; Hofmann, F.; Gutiérrez, M. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res. Ther. 2011, 13, R4.
   PubMed Web of Science ®Google Scholar
• Howard, R.G.; Pillinger, M.H.; Gyftopoulos, S.; Thiele, R.G.; Swearingen, C.J.; Samuels, J. Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers. Arthritis Care Res. 2011, 63, 1456–1462.
   Web of Science ®Google Scholar
• de Miguel, E.; Puig, J.G.; Castillo, C.; Peiteado, D.; Torres, R.J.; Martín-Mola, E. Diagnosis of gout in patients with asymptomatic hyperuricemia: a pilot study. Ann. Rheum. Dis. 2012, 71, 157–158.
   PubMed Web of Science ®Google Scholar
• Peiteado, D.; De Miguel, E.; Villalba, A.; Ordóñez, M.C.; Castillo, C.; Martín-Mola, E. Value of a short four-joint ultrasound test for gout diagnosis: a pilot study. Clin. Exp. Rheumatol. 2012, 30, 830–837.
   PubMed Web of Science ®Google Scholar
• Chowalloor, P.V.; Keen, H.I. A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia. Ann. Rheum. Dis. 2013, 72, 638–645.
   PubMed Web of Science ®Google Scholar
• Peiteado, D.; Villalba, A.; Martín-Mola, E.; de Miguel, E.; Reduction but not disappearance of Doppler signal after two years of treatment for gout. Do we need a more intensive treatment? Clin. Exp. Rheumatol. 2015, 33, 385–390.
   PubMed Web of Science ®Google Scholar
• Mejía-Chew, C.; Torres, R.J.; de Miguel, E.; Puig, J.G. Resolution of massive tophaceous gout with three urate-lowering drugs. Am. J. Med. 2013, 126, e9–e10.
   Google Scholar
• Bailén, R.; González Senac, N.; López, M.M.; Llena, M.L.; Migoya, M.M.; Rodríguez, T.; de Miguel, E.; Torres, R.J.; Puig, J.G. Efficacy and safety of a urate lowering regimen in primary gout. Nucleosides, Nucleotides Nucleic Acids 2014, 33, 174–180.
   PubMed Web of Science ®Google Scholar